Continuing Evaluation of the LungPoint ATV System

NCT02130128 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2015-06-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and performance of the LungPoint ATV System in patients who are scheduled for standard bronchoscopy to diagnose highly suspicious lung cancer.

Conditions

Interventions

DEVICE

LungPoint ATV System

The LungPoint ATV System is an image-guided navigation system used to access tissue samples in the lungs.

Sponsors & Collaborators

  • Broncus Medical Inc

    lead INDUSTRY

Principal Investigators

  • Felix Herth, MD · Heidelberg University

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02130128 on ClinicalTrials.gov